U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters12-09 15:07
U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Dec 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AstraZeneca, Confluent and Pepsico, on Tuesday.

HIGHLIGHTS

* AstraZeneca AZN.O: TD Cowen raises target price to $105 from $95

* Confluent Inc CFLT.O: Raymond James cuts to market perform from outperform

* Kymera Therapeutics Inc KYMR.O: Piper Sandler raises target price to $125 from $98

* Pepsico PEP.O: Piper Sandler raises target price to $172 from $161

* Warner Bros Discovery Inc WBD.O: Seaport Research Partners cuts to neutral from buy

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Adobe Inc ADBE.O: Stifel cuts target price to $450 from $480

* Air Products APD.N: Jefferies cuts target price to $300 from $350

* Alexander & Baldwin Inc (Hawaii) ALEX.N: Piper Sandler cuts to neutral from overweight

* Align Technology ALGN.O: Barclays initiates coverage with equal-weight rating

* Align Technology ALGN.O: Barclays initiates coverage with target price $170

* American Airlines AAL.O: BMO initiates coverage with market perform rating

* American Airlines AAL.O: BMO initiates coverage with target price $16.75

* Amneal Pharmaceuticals AMRX.O: Barclays initiates coverage with target price $15

* Amneal Pharmaceuticals AMRX.O: Barclays initiates coverage with overweight rating

* Amphastar Pharmaceuticals Inc AMPH.O: Barclays initiates coverage with equal weight rating

* Amphastar Pharmaceuticals Inc AMPH.O: Barclays initiates coverage with target price $30

* Ani Pharmaceuticals Inc ANIP.O: Barclays initiates coverage with overweight rating

* Ani Pharmaceuticals Inc ANIP.O: Barclays initiates coverage with target price $100

* Antero Resources Corp AR.N: BMO raises target price to $40 from $37

* Antero Resources Corp AR.N: JP Morgan raises target price to $42 from $39

* Antero Resources Corp AR.N: Morgan Stanley raises target price to $48.00 from $44.00

* Apple Inc AAPL.O: Citigroup raises target price to $330 from $315

* Arrowhead Pharmaceuticals ARWR.O: BofA Global Research raises price objective to $81 from $62

* AstraZeneca AZN.O: TD Cowen raises target price to $105 from $95

* BorgWarner Inc. BWA.N: Wells Fargo cuts target price to $52 from $54

* Brightspring Health Services Inc BTSG.O: BofA Global Research raises price objective to $41 from $38

* Broadcom Inc AVGO.O: Rosenblatt Securities raises target price to $440 from $400

* California Resources Corporation CRC.N: Wells Fargo cuts target price to $56 from $58

* Cardinal Health CAH.N: Barclays initiates coverage with overweight rating and PT $243

* Cencora COR.N: Barclays initiates coverage with overweight rating and PT $400

* Ceribell Inc CBLL.O: TD Cowen raises target price to $29 from $20

* Chimera Investment Corp CIM.N: RBC cuts to sector perform from outperform

* Chimera Investment Corp CIM.N: RBC raises target price to $13 from $6

* Ciena Corp CIEN.N: Stifel raises target price to $230 from $152

* Colgate-Palmolive Co CL.N: RBC raises to outperform from sector perform

* Collegium Pharmaceutical Inc. COLL.O: Barclays initiates coverage with overweight rating

* Collegium Pharmaceutical Inc. COLL.O: Barclays initiates coverage with target price $58

* Confluent CFLT.O: Deutsche Bank cuts to hold from buy

* Confluent CFLT.O: Deutsche Bank raises target price to $31 from $29

* Confluent Inc CFLT.O: Canaccord Genuity cuts to hold from buy; ups PT to $31 from $27

* Confluent Inc CFLT.O: D.A. Davidson cuts to neutral from buy; raises PT to $31 from $29

* Confluent Inc CFLT.O: Deutsche Bank cuts to hold from buy; raises PT to $31 from $29

* Confluent Inc CFLT.O: Mizuho cuts to neutral from outperform; ups PT to $31 from $26

* Confluent Inc CFLT.O: Needham cuts to hold from buy

* Confluent Inc CFLT.O: Oppenheimer cuts to perform from outperform

* Confluent Inc CFLT.O: Raymond James cuts to market perform from outperform

* Confluent Inc CFLT.O: RBC cuts to sector perform from outperform

* Confluent Inc CFLT.O: RBC raises target price to $31 from $30

* Confluent Inc CFLT.O: Stephens cuts to equal-weight from overweight

* Confluent Inc CFLT.O: Stephens raises target price to $31 from $29

* Confluent Inc CFLT.O: TD Cowen raises target price to $31 from $27

* Confluent Inc CFLT.O: Truist Securities cuts to hold from buy; ups PT to $31 from $29

* Confluent Inc CFLT.O: UBS cuts to neutral from buy

* Confluent Inc CFLT.O: UBS raises target price to $31 from $29

* Confluent Inc CFLT.O: Wells Fargo cuts to equal weight from overweight

* Confluent Inc CFLT.O: Wells Fargo raises target price to $31 from $30

* Cross Country Healthcare Inc CCRN.O: UBS cuts target price to $9 from $16.5

* Cullinan Therapeutics Inc CGEM.O: Wedbush raises target price to $34 from $25

* Dana Incorporated DAN.N: Wells Fargo raises target price to $23 from $21

* Deere & Co DE.N: Jefferies raises target price to $475 from $440

* Definitive Healthcare Corp DH.O: Barclays cuts target price to $2.75 from $3

* Delta Air Lines Inc DAL.N: BMO initiates coverage with outperform rating; PT $80

* Dentsply Sirona XRAY.O: Barclays initiates coverage with underweight rating and PT $12

* Dollar Tree Inc DLTR.O: Barclays raises target price to $136 from $120

* Doximity DOCS.N: Barclays initiates coverage with overweight rating and PT $63

* Dyne Therapeutics Inc DYN.O: Bernstein raises target price to $23 from $21

* Dyne Therapeutics Inc DYN.O: Morgan Stanley raises target price to $50.00 from $46.00

* Elanco Animal Health Inc. ELAN.N: Barclays initiates coverage with overweight rating

* Elanco Animal Health Inc. ELAN.N: Barclays initiates coverage with target price $30

* Envista Holdings Corp. NVST.N: Barclays initiates coverage with overweight rating

* Envista Holdings Corp. NVST.N: Barclays initiates coverage with target price $24

* FMC Corp. FMC.N: Barclays cuts target price to $13 from $16

* FMC Corp. FMC.N: Barclays cuts to underweight from equal-weight

* Galaxy Digital Inc GLXY.O: Citizens initiates coverage with market outperform rating

* Galaxy Digital Inc GLXY.O: Citizens initiates coverage with target price $60

* General Motors Co. GM.N: Wells Fargo raises target price to $48 from $46

* Glaukos Corp GKOS.N: Needham raises target price to $125 from $117

* Goodrx Holdings Inc. GDRX.O: Barclays initiates coverage with target price $3

* Goodrx Holdings Inc. GDRX.O: Barclays initiates coverage with underweight rating

* Graphic Packaging Holding Co GPK.N: Baird cuts target price to $18 from $24

* Healthequity HQY.O: Barclays initiates coverage with overweight rating and PT $118

* Henry Schein HSIC.O: Barclays initiates coverage with overweight rating and PT $86

* Hims & Hers Health HIMS.N: Barclays initiates coverage with overweight rating

* Hims & Hers Health HIMS.N: Barclays initiates coverage with target price $48

* Hormel Foods Corp. HRL.N: Barclays cuts target price to $30 from $31

* IBM IBM.N: Stifel raises target price to $325 from $295

* Idexx Laboratories, Inc. IDXX.O: Barclays initiates coverage with overweight rating

* Idexx Laboratories, Inc. IDXX.O: Barclays initiates coverage with target price $850

* Immix Biopharma, Inc. IMMX.O: H.C. Wainwright raises target price to $12 from $8

* Ionis Pharmaceuticals IONS.O: BofA Global Research ups price objective to $97 from $86

* Jack In the Box Inc JACK.O: RBC raises target price to $25 from $16

* Keycorp KEY.N: Piper Sandler raises target price to $22 from $20

* Kroger Co KR.N: Citigroup cuts target price to $68 from $74

* Kymera Therapeutics KYMR.O: Barclays raises target price to $119 from $70

* Kymera Therapeutics KYMR.O: Oppenheimer raises target price to $120 from $67

* Kymera Therapeutics Inc KYMR.O: BofA Global Research ups price objective to $112 from $71

* Kymera Therapeutics Inc KYMR.O: BTIG raises target price to $138 from $75

* Kymera Therapeutics Inc KYMR.O: H.C. Wainwright raises target price to $134 from $84

* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises target price to $127.00 from $73.00

* Kymera Therapeutics Inc KYMR.O: Piper Sandler raises target price to $125 from $98

* Kymera Therapeutics Inc KYMR.O: Truist Securities raises target price to $116 from $80

* Kymera Therapeutics Inc KYMR.O: Wells Fargo raises target price to $116 from $69

* Lear Corporation LEA.N: Wells Fargo cuts target price to $107 from $112

* Lifestance Health Group Inc LFST.O: Barclays initiates coverage with overweight rating

* Lifestance Health Group Inc LFST.O: Barclays initiates coverage with target price $8

* Ligand Pharmaceuticals Inc LGND.O: Citigroup initiates coverage with buy rating

* Ligand Pharmaceuticals Inc LGND.O: Citigroup initiates coverage with price target $270

* Lyell Immunopharma Inc LYEL.O: H.C. Wainwright raises target price to $45 from $20

* Lyell Immunopharma Inc LYEL.O: H.C. Wainwright raises to buy from neutral

* Lyft, Inc. LYFT.O: Wells Fargo raises target price to $26 from $20

* Mannkind Corp MNKD.O: Leerink Partners raises target price to $9 from $7

* McKesson MCK.N: Barclays initiates coverage with overweight rating and PT $960

* Micron Technology Inc MU.O: Bernstein raises target price to $270 from $170

* Mirum Pharmaceuticals MIRM.O: Morgan Stanley raises target price to $95.00 from $81.00

* Mosaic MOS.N: Barclays cuts target price to $31 from $35

* $Nextera Energy Inc(NEE-N)$ NEE.N: BTIG raises target price to $100 from $98

* Nike Inc NKE.N: Citigroup cuts target price to $70 from $74

* NRG Energy Inc NRG.N: UBS initiates coverage with buy rating and target price $211

* Nurix Therapeutics Inc NRIX.O: BTIG raises target price to $30 from $27

* Omnicell Inc OMCL.O: Benchmark raises target price to $50 from $45

* Option Care Health OPCH.O: Deutsche Bank raises target price to $36 from $31

* Option Care Health Inc OPCH.O: BofA Global Research ups price objective to $35 from $32

* Oracle Corp. ORCL.N: Barclays cuts target price to $330 from $400

* Organon OGN.N: Barclays initiates coverage with underweight rating and PT $7.5

* Otis Worldwide Corp OTIS.N: Exane BNP Paribas raises to outperform from neutral

* Pacira Biosciences PCRX.O: Barclays initiates coverage with equal-weight rating

* Pacira Biosciences PCRX.O: Barclays initiates coverage with target price $27

* Paramount Skydance Corporation PSKY.O: Morgan Stanley raises target to $12.00 from $10.00

* Paychex Inc PAYX.O: BMO cuts target price to $121 from $140

* Paychex, Inc. PAYX.O: Wells Fargo cuts target price to $116 from $128

* PayPal Holdings, Inc. PYPL.O: Wells Fargo cuts target price to $67 from $74

* Penske Automotive Group PAG.N: BofA Global Research reinstates with buy rating

* Penske Automotive Group PAG.N: BofA Global Research reinstates with price objective $195

* Peoples Financial Services Corp PFIS.O: Stephens cuts to equal-weight from overweight

* Pepsico PEP.O: Jefferies raises target price to $164 from $163

* Pepsico PEP.O: Piper Sandler raises target price to $172 from $161

* Phathom Pharmaceuticals Inc. PHAT.O: Barclays initiates coverage with equal-weight rating

* Phathom Pharmaceuticals Inc. PHAT.O: Barclays initiates coverage with target price $16

* Phreesia PHR.N: Barclays initiates coverage with overweight rating and PT $26

* Pilgrim'S Pride Corp PPC.O: Barclays cuts target price to $45 from $49

* Planet Fitness Inc PLNT.N: RBC raises target price to $135 from $120

* Progressive Corp PGR.N: BMO cuts target price to $256 from $260

* Progressive Corp PGR.N: BofA Global Research cuts price objective to $348 from $350

* Progyny PGNY.O: Barclays initiates coverage with overweight rating and PT $29

* Pseg PEG.N: BofA Global Research adds stock to its US 1 list

* Rapport Therapeutics, Inc. RAPP.O: H.C. Wainwright raises target price to $40 from $34

* RPM International Inc RPM.N: RBC raises target price to $132 from $121

* RPM International Inc RPM.N: RBC raises to outperform from sector perform

* Sarepta Therapeutics Inc SRPT.O: Wedbush initiates coverage with outperform rating

* Sarepta Therapeutics Inc SRPT.O: Wedbush initiates coverage with target price $32

* SL Green Realty Corp SLG.N: Deutsche Bank cuts target price to $46 from $60

* SLM Corp SLM.O: Morgan Stanley cuts target price to $31.00 from $36.00

* SLM Corp SLM.O: Morgan Stanley cuts to equal-weight from overweight

* Southwest Airlines Co LUV.N: BMO initiates coverage with market perform rating; PT $43

* Southwest Gas Holdings Inc SWX.N: Jefferies cuts target price to $89 from $92

* Structure Therapeutics Inc GPCR.O: Citigroup raises target price to $100 from $60

* Synopsys Inc SNPS.O: Rosenblatt Securities cuts target price to $560 from $605

* Synopsys Inc SNPS.O: Rosenblatt Securities raises to buy from neutral

* Talkspace TALK.O: Barclays initiates coverage with equal-weight rating and PT $3.5

* Tarsus Pharmaceuticals TARS.O: Barclays initiates coverage with overweight rating

* Tarsus Pharmaceuticals TARS.O: Barclays initiates coverage with target price $100

* Teladoc Health TDOC.N: Barclays initiates coverage with target price $8.5

* Teladoc Health TDOC.N: Barclays initiates coverage with equal-weight rating

* Terns Pharmaceuticals TERN.O: Barclays raises target price to $56 from $36

* Terns Pharmaceuticals Inc TERN.O: BMO raises target price to $54 from $35

* Terns Pharmaceuticals Inc TERN.O: H.C. Wainwright raises target price to $60 from $20

* Terns Pharmaceuticals Inc TERN.O: Mizuho raises target price to $54 from $33

* Terns Pharmaceuticals Inc TERN.O: Oppenheimer raises target price to $58 from $28

* Terns Pharmaceuticals Inc TERN.O: Oppenheimer raises target price to $58 from $28

* Terns Pharmaceuticals Inc TERN.O: Truist Securities raises target price to $56 from $35

* Thor Industries Inc THO.N: Truist Securities raises target price to $112 from $110

* Truist Financial Corp TFC.N: Piper Sandler raises target price to $50 from $48

* Tyler Technologies Inc TYL.N: D.A. Davidson cuts target price to $510 from $540

* United Airlines UAL.O: BMO initiates coverage with outperform rating; target price $125

* Vail Resorts MTN.N: Deutsche Bank raises target price to $162 from $159

* Viatris Inc. VTRS.O: Barclays initiates coverage with overweight rating and PT $15

* Visteon Corp. VC.O: Wells Fargo cuts target price to $148 from $151

* Vor Biopharma Inc VOR.O: JP Morgan initiates coverage with overweight rating; PT $43

* Warner Bros Discovery Inc WBD.O: Deutsche Bank raises target price to $29.50 from $26

* Warner Bros Discovery Inc WBD.O: Seaport Research Partners cuts to neutral from buy

* Waystar Holding Corp. WAY.O: Barclays cuts target price to $42 from $50

* Wells Fargo WFC.N: Piper Sandler raises target price to $100 from $93

* Weyerhaeuser Co WY.N: CIBC cuts target price to $27 from $30

* Wingstop Inc WING.O: RBC raises target price to $350 from $300

* Wynn Resorts Ltd WYNN.O: BofA Global Research raises price objective to $150 from $140

* Xeris Biopharma Holdings Inc. XERS.O: Barclays initiates coverage with overweight rating

* Xeris Biopharma Holdings Inc. XERS.O: Barclays initiates coverage with target price $9

* Zoetis Inc. ZTS.N: Barclays initiates coverage with equal-weight rating and PT $136

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment